Join the club for FREE to access the whole archive and other member benefits.

Drug Discovery Today

Journal publishing research on all aspects of preclinical drug discovery.

Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.

Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.

Visit website: https://www.journals.elsevier.com/drug-discovery-today

 ELSpharma

See also: Company Elsevier - Elsevier is a global information analytics business in science, health and technology

Details last updated 18-Dec-2020

Drug Discovery Today News

AI-identified molecules show an impressive 80-90% success rate in Phase I trials

AI-identified molecules show an impressive 80-90% success rate in Phase I trials

Live Forever Club - 20-May-2024

These early findings suggest AI could double the productivity of drug research

João Pedro de Magalhães discusses longevity pharmacology and importance of human trials

João Pedro de Magalhães discusses longevity pharmacology and importance of human trials

Longevity Technology - 23-Mar-2021

Advances in longevity pharmacology to revolutionize healthcare with personalized therapies

Longevity pharmacology promises to revolutionize healthcare industry

Longevity pharmacology promises to revolutionize healthcare industry

Lifespan.io (LEAF) - 24-Feb-2021

Despite challenges, many companies and clinical trials in longevity field are constantly evolving